Mass Spectrometry Reveals Changes in MHC I Antigen Presentation After Lentivector Expression of a Gene Regulation System
The rapamycin-inducible gene regulation system was designed to minimize immune reactions in man and may thus be suited for gene therapy. We assessed whether this system indeed induces no immune responses. The protein components of the regulation system were produced in the human cell lines HEK 293T,...
Saved in:
Main Authors: | Roland Vogel (Author), Reem Al-Daccak (Author), Oliver Drews (Author), Jessy Alonzeau (Author), Gabor Mester (Author), Dominique Charron (Author), Stefan Stevanovic (Author), Jacques Mallet (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Evasion through Loss of MHC Class I Antigen Presentation
by: Annissa Ambaravista Nasution, et al.
Published: (2023) -
MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer
by: Jing Yao Wang, et al.
Published: (2015) -
Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
by: Jing Yu, et al.
Published: (2022) -
2023 MHC Awards and Recognition
by: Amy VandenBerg, PharmD, BCPP, et al.
Published: (2024) -
2022 MHC Awards and Recognition
by: Erica A. K. Davis, PharmD, BCPS, BCPP, et al.
Published: (2023)